839 related articles for article (PubMed ID: 15867776)
1. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation is unnecessary after biological aortic valve replacement.
Moinuddeen K; Quin J; Shaw R; Dewar M; Tellides G; Kopf G; Elefteriades J
Circulation; 1998 Nov; 98(19 Suppl):II95-8; discussion II98-9. PubMed ID: 9852888
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
5. Operative risk of reoperative aortic valve replacement.
Potter DD; Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Schaff HV; Orszulak TA
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):94-103. PubMed ID: 15632830
[TBL] [Abstract][Full Text] [Related]
6. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
7. Late incidence and determinants of stroke after aortic and mitral valve replacement.
Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
[TBL] [Abstract][Full Text] [Related]
8. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
[TBL] [Abstract][Full Text] [Related]
9. Mitral valve repair and bioprosthetic replacement without postoperative anticoagulation does not increase the risk of stroke or mortality.
Schwann TA; Engoren M; Bonnell M; Clancy C; Khouri S; Kabour A; Jamil T; Habib RH
Eur J Cardiothorac Surg; 2013 Jul; 44(1):24-31. PubMed ID: 23293318
[TBL] [Abstract][Full Text] [Related]
10. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.
Stassano P; Di Tommaso L; Monaco M; Iorio F; Pepino P; Spampinato N; Vosa C
J Am Coll Cardiol; 2009 Nov; 54(20):1862-8. PubMed ID: 19892237
[TBL] [Abstract][Full Text] [Related]
11. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
[TBL] [Abstract][Full Text] [Related]
12. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Colli A; Mestres CA; Castella M; Gherli T
J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
[TBL] [Abstract][Full Text] [Related]
13. Re-do aortic valve replacement: does a previous homograft influence the operative outcome?
Kumar P; Athanasiou T; Ali A; Nair S; Oz BS; DeSouza A; Moat N; Shore DF; Pepper JR
J Heart Valve Dis; 2004 Nov; 13(6):904-12; discussion 912-3. PubMed ID: 15597580
[TBL] [Abstract][Full Text] [Related]
14. Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?
Jamieson WR; Moffatt-Bruce SD; Skarsgard P; Hadi MA; Ye J; Fradet GJ; Abel JG; Janusz MT; Cheung A; Germann E
Ann Thorac Surg; 2007 Feb; 83(2):549-56; discussion 556-7. PubMed ID: 17257986
[TBL] [Abstract][Full Text] [Related]
15. Aortic valve replacement: choice between mechanical valves and bioprostheses.
Silberman S; Oren A; Dotan M; Merin O; Fink D; Deeb M; Bitran D
J Card Surg; 2008; 23(4):299-306. PubMed ID: 18462345
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy following bioprosthetic aortic valve replacement.
Nowell J; Wilton E; Markus H; Jahangiri M
Eur J Cardiothorac Surg; 2007 Apr; 31(4):578-85. PubMed ID: 17267235
[TBL] [Abstract][Full Text] [Related]
17. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z
Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
[TBL] [Abstract][Full Text] [Related]
18. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factors as predictors of early and late survival after bioprosthetic valve replacement for aortic stenosis.
Le Tourneau T; Marechaux S; Vincentelli A; Ennezat PV; Modine T; Polge AS; Fayad G; Prat A; Warembourg H; Deklunder G
J Heart Valve Dis; 2007 Sep; 16(5):483-8. PubMed ID: 17944119
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of aortic valve disease in the elderly: A retrospective comparative study of valve choice using propensity score analysis.
Accola KD; Scott ML; Palmer GJ; Thompson PA; Sand ME; Suarez-Cavalier JE; Bott JN; Ebra G
J Heart Valve Dis; 2008 Jul; 17(4):355-64; discussion 365. PubMed ID: 18751463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
